Surgery Partners (SGRY) Preferred Stock Liabilities (2017 - 2021)
Surgery Partners (SGRY) has disclosed Preferred Stock Liabilities for 5 consecutive years, with $439.7 million as the latest value for Q1 2021.
- Quarterly Preferred Stock Liabilities rose 8.7% to $439.7 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $439.7 million through Mar 2021, up 8.7% year-over-year, with the annual reading at $434.5 million for FY2020, 10.0% up from the prior year.
- Preferred Stock Liabilities hit $439.7 million in Q1 2021 for Surgery Partners, up from $434.5 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $439.7 million in Q1 2021 to a low of $330.8 million in Q3 2017.
- Historically, Preferred Stock Liabilities has averaged $382.9 million across 5 years, with a median of $381.2 million in 2019.
- Biggest five-year swings in Preferred Stock Liabilities: increased 10.0% in 2020 and later increased 8.7% in 2021.
- Year by year, Preferred Stock Liabilities stood at $330.8 million in 2017, then grew by 8.61% to $359.3 million in 2018, then rose by 9.94% to $395.0 million in 2019, then rose by 10.0% to $434.5 million in 2020, then rose by 1.2% to $439.7 million in 2021.
- Business Quant data shows Preferred Stock Liabilities for SGRY at $439.7 million in Q1 2021, $434.5 million in Q4 2020, and $424.2 million in Q3 2020.